ENTRY       hsa05170                    Pathway
NAME        Human immunodeficiency virus 1 infection - Homo sapiens (human)
DESCRIPTION Human immunodeficiency virus type 1 (HIV-1) , the causative agent of AIDS (acquired immunodeficiency syndrome), is a lentivirus belonging to the Retroviridae family. The primary cell surface receptor for HIV-1, the CD4 protein, and the co-receptor for HIV-1, either CCR5 or CXCR4, are found on macrophages and T lymphocytes. At the earliest step, sequential binding of virus envelope (Env) glycoprotein gp120 to CD4 and the co-receptor CCR5 or CXCR4 facilitates HIV-1 entry and has the potential to trigger critical signaling that may favor viral replication. At advanced stages of the disease, HIV-1 infection results in dramatic induction of T-cell (CD4+ T and CD8+ T cell) apoptosis both in infected and uninfected bystander T cells, a hallmark of HIV-1 pathogenesis. On the contrary, macrophages are resistant to the cytopathic effect of HIV-1 and produce virus for longer periods of time.
CLASS       Human Diseases; Infectious disease: viral
PATHWAY_MAP hsa05170  Human immunodeficiency virus 1 infection
NETWORK     nt06161  Human immunodeficiency virus 1 (HIV-1)
            nt06516  TNF signaling
            nt06517  TLR signaling
            nt06520  CGAS-STING signaling
            nt06524  Apoptosis
            nt06533  Chemokine signaling
  ELEMENT   N00431  HIV gp120 to CXCR4-GNAI-PI3K-BAD signaling pathway
            N00432  HIV gp120 to CXCR4-GNAQ-PLCB/G-calcineurin
            N00434  HIV gp120 to CXCR4-GNB/G-RAC signaling pathway
            N00436  HIV Tat to TLR2/4-NFKB signaling pathway
            N00437  HIV Vpu to TLR2/4-NFKB signaling pathway
            N00439  HIV Nef to TLR2/4-MAPK signaling pathway
            N00440  HIV Vpu/Vif/Vpr to cGAS-STING signaling pathway
            N00441  HIV gp120 to TNF-NFKB signaling pathway
            N00442  HIV Nef to TNF-NFKB signaling pathway
            N00443  HIV Vpr/Nef/Tat to TNF-NFKB signaling pathway
            N00445  HIV Tat/Nef to TNF-p38 signaling pathway
            N00447  HIV Vpr/Tat to TNF-JNK signaling pathway
            N00448  HIV Tat/Nef to crosstalk between extrinsic and intrinsic apoptotic pathways
            N00449  HIV Tat/Nef to crosstalk between extrinsic and intrinsic apoptotic pathways
            N00450  HIV Tat to intrinsic apoptotic pathway
            N00451  HIV Tat to intrinsic apoptotic pathway
            N00452  HIV Nef to intrinsic apoptotic pathway
            N00453  HIV Vpr to intrinsic apoptotic pathway
            N00454  HIV Vpr to intrinsic apoptotic pathway
            N00456  HIV Vpr to CDC25-cell cycle G2M
            N00457  HIV Vpr to cell cycle G2M
            N00458  HIV Vpr to CDC25-cell cycle G2M
            N00460  HIV Vpr to WEE1-cell cycle G2M
            N00461  HIV Nef to antigen processing and presentation by MHC class I molecules
DISEASE     H00406  Acquired immunodeficiency syndrome (AIDS)
            H01563  HIV infection
DRUG        D06670  Maraviroc (JAN/INN)
            D09575  Ibalizumab (USAN/INN)
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            10053  AP1M2; adaptor related protein complex 1 subunit mu 2 [KO:K12393]
            100913187  APOBEC3A_B; APOBEC3A and APOBEC3B deletion hybrid [KO:K18750] [EC:3.5.4.-]
            10298  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]
            10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]
            10681  GNB5; G protein subunit beta 5 [KO:K04539]
            106821730  BUB1B-PAK6; BUB1B-PAK6 readthrough [KO:K05735] [EC:2.7.11.1]
            1072  CFL1; cofilin 1 [KO:K05765]
            1073  CFL2; cofilin 2 [KO:K05765]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            1111  CHEK1; checkpoint kinase 1 [KO:K02216] [EC:2.7.11.1]
            1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]
            115004  CGAS; cyclic GMP-AMP synthase [KO:K17834] [EC:2.7.7.86]
            1174  AP1S1; adaptor related protein complex 1 subunit sigma 1 [KO:K12394]
            1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]
            130340  AP1S3; adaptor related protein complex 1 subunit sigma 3 [KO:K12395]
            1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]
            1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]
            140564  APOBEC3D; apolipoprotein B mRNA editing enzyme catalytic subunit 3D [KO:K18750] [EC:3.5.4.-]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            162  AP1B1; adaptor related protein complex 1 subunit beta 1 [KO:K12392]
            163688  CALML6; calmodulin like 6 [KO:K02183]
            164  AP1G1; adaptor related protein complex 1 subunit gamma 1 [KO:K12391]
            1642  DDB1; damage specific DNA binding protein 1 [KO:K10610]
            164668  APOBEC3H; apolipoprotein B mRNA editing enzyme catalytic subunit 3H [KO:K18750] [EC:3.5.4.-]
            200315  APOBEC3A; apolipoprotein B mRNA editing enzyme catalytic subunit 3A [KO:K18750] [EC:3.5.4.-]
            200316  APOBEC3F; apolipoprotein B mRNA editing enzyme catalytic subunit 3F [KO:K18750] [EC:3.5.4.-]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]
            23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]
            23291  FBXW11; F-box and WD repeat domain containing 11 [KO:K03362]
            2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]
            2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]
            25939  SAMHD1; SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 [KO:K22544] [EC:3.1.5.-]
            27350  APOBEC3C; apolipoprotein B mRNA editing enzyme catalytic subunit 3C [KO:K18750] [EC:3.5.4.-]
            2767  GNA11; G protein subunit alpha 11 [KO:K04635]
            2770  GNAI1; G protein subunit alpha i1 [KO:K04630]
            2771  GNAI2; G protein subunit alpha i2 [KO:K04630]
            2773  GNAI3; G protein subunit alpha i3 [KO:K04630]
            2775  GNAO1; G protein subunit alpha o1 [KO:K04534]
            2776  GNAQ; G protein subunit alpha q [KO:K04634]
            2782  GNB1; G protein subunit beta 1 [KO:K04536]
            2783  GNB2; G protein subunit beta 2 [KO:K04537]
            2784  GNB3; G protein subunit beta 3 [KO:K07825]
            2785  GNG3; G protein subunit gamma 3 [KO:K04540]
            2786  GNG4; G protein subunit gamma 4 [KO:K04541]
            2787  GNG5; G protein subunit gamma 5 [KO:K04542]
            2788  GNG7; G protein subunit gamma 7 [KO:K04543]
            2790  GNG10; G protein subunit gamma 10 [KO:K04545]
            2791  GNG11; G protein subunit gamma 11 [KO:K04546]
            2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]
            2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]
            29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]
            2923  PDIA3; protein disulfide isomerase family A member 3 [KO:K08056] [EC:5.3.4.1]
            3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]
            3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]
            3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]
            3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]
            3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]
            3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]
            3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
            340061  STING1; stimulator of interferon response cGAMP interactor 1 [KO:K12654]
            3439  IFNA1; interferon alpha 1 [KO:K05414]
            3440  IFNA2; interferon alpha 2 [KO:K05414]
            3441  IFNA4; interferon alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon alpha 10 [KO:K05414]
            3447  IFNA13; interferon alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            3449  IFNA16; interferon alpha 16 [KO:K05414]
            3451  IFNA17; interferon alpha 17 [KO:K05414]
            3452  IFNA21; interferon alpha 21 [KO:K05414]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            355  FAS; Fas cell surface death receptor [KO:K04390]
            3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
            356  FASLG; Fas ligand [KO:K04389]
            3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]
            3661  IRF3; interferon regulatory factor 3 [KO:K05411]
            3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
            3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
            3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
            3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]
            3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]
            3984  LIMK1; LIM domain kinase 1 [KO:K05743] [EC:2.7.11.1]
            3985  LIMK2; LIM domain kinase 2 [KO:K05744] [EC:2.7.11.1]
            4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]
            472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]
            4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]
            4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]
            4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]
            4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]
            494551  WEE2; WEE2 oocyte meiosis inhibiting kinase [KO:K06632] [EC:2.7.11.1]
            5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]
            5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]
            5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]
            51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]
            51764  GNG13; G protein subunit gamma 13 [KO:K04547]
            51806  CALML5; calmodulin like 5 [KO:K02183]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
            5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
            54205  CYCS; cytochrome c, somatic [KO:K08738]
            54331  GNG2; G protein subunit gamma 2 [KO:K07826]
            545  ATR; ATR serine/threonine kinase [KO:K06640] [EC:2.7.11.1]
            5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]
            5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]
            5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
            5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
            5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
            5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            55970  GNG12; G protein subunit gamma 12 [KO:K04347]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
            5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
            5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]
            567  B2M; beta-2-microglobulin [KO:K08055]
            56924  PAK6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]
            57144  PAK5; p21 (RAC1) activated kinase 5 [KO:K05736] [EC:2.7.11.1]
            572  BAD; BCL2 associated agonist of cell death [KO:K02158]
            5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]
            578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]
            581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]
            5829  PXN; paxillin [KO:K05760]
            5879  RAC1; Rac family small GTPase 1 [KO:K04392]
            5880  RAC2; Rac family small GTPase 2 [KO:K07860]
            5881  RAC3; Rac family small GTPase 3 [KO:K07861]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            59345  GNB4; G protein subunit beta 4 [KO:K04538]
            596  BCL2; BCL2 apoptosis regulator [KO:K02161]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            598  BCL2L1; BCL2 like 1 [KO:K04570]
            60489  APOBEC3G; apolipoprotein B mRNA editing enzyme catalytic subunit 3G [KO:K18750] [EC:3.5.4.-]
            6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]
            6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            637  BID; BH3 interacting domain death agonist [KO:K04726]
            6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]
            684  BST2; bone marrow stromal cell antigen 2 [KO:K06731]
            6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]
            6890  TAP1; transporter 1, ATP binding cassette subfamily B member [KO:K05653] [EC:7.4.2.14]
            6891  TAP2; transporter 2, ATP binding cassette subfamily B member [KO:K05654] [EC:7.4.2.14]
            6892  TAPBP; TAP binding protein [KO:K08058]
            6921  ELOC; elongin C [KO:K03872]
            6923  ELOB; elongin B [KO:K03873]
            7097  TLR2; toll like receptor 2 [KO:K10159]
            7099  TLR4; toll like receptor 4 [KO:K10160]
            7124  TNF; tumor necrosis factor [KO:K03156]
            7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]
            7133  TNFRSF1B; TNF receptor superfamily member 1B [KO:K05141]
            7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]
            7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]
            7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]
            7465  WEE1; WEE1 G2 checkpoint kinase [KO:K06632] [EC:2.7.11.1]
            7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]
            801  CALM1; calmodulin 1 [KO:K02183]
            805  CALM2; calmodulin 2 [KO:K02183]
            8065  CUL5; cullin 5 [KO:K10612]
            808  CALM3; calmodulin 3 [KO:K02183]
            810  CALML3; calmodulin like 3 [KO:K02183]
            811  CALR; calreticulin [KO:K08057]
            836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]
            841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]
            842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]
            8450  CUL4B; cullin 4B [KO:K10609]
            8451  CUL4A; cullin 4A [KO:K10609]
            8454  CUL1; cullin 1 [KO:K03347]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]
            85363  TRIM5; tripartite motif containing 5 [KO:K10648] [EC:2.3.2.27]
            85417  CCNB3; cyclin B3 [KO:K21771]
            8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]
            8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]
            8772  FADD; Fas associated via death domain [KO:K02373]
            8905  AP1S2; adaptor related protein complex 1 subunit sigma 2 [KO:K12394]
            8906  AP1G2; adaptor related protein complex 1 subunit gamma 2 [KO:K12391]
            8907  AP1M1; adaptor related protein complex 1 subunit mu 1 [KO:K12393]
            891  CCNB1; cyclin B1 [KO:K05868]
            8945  BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase [KO:K03362]
            9133  CCNB2; cyclin B2 [KO:K21770]
            915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]
            916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]
            917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]
            91860  CALML4; calmodulin like 4 [KO:K02183]
            919  CD247; CD247 molecule [KO:K06453]
            920  CD4; CD4 molecule [KO:K06454]
            94235  GNG8; G protein subunit gamma 8 [KO:K04544]
            9582  APOBEC3B; apolipoprotein B mRNA editing enzyme catalytic subunit 3B [KO:K18750] [EC:3.5.4.-]
            9616  RNF7; ring finger protein 7 [KO:K10611]
            9730  DCAF1; DDB1 and CUL4 associated factor 1 [KO:K11789] [EC:2.7.11.1]
            983  CDK1; cyclin dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]
            995  CDC25C; cell division cycle 25C [KO:K05867] [EC:3.1.3.48]
            9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]
COMPOUND    C00076  Calcium cation
            C00165  Diacylglycerol
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
            C20640  Cyclic GMP-AMP
REFERENCE   PMID:22749173
  AUTHORS   Evans VA, Khoury G, Saleh S, Cameron PU, Lewin SR
  TITLE     HIV persistence: chemokines and their signalling pathways.
  JOURNAL   Cytokine Growth Factor Rev 23:151-7 (2012)
            DOI:10.1016/j.cytogfr.2012.05.002
REFERENCE   PMID:23806647
  AUTHORS   Abbas W, Herbein G
  TITLE     Plasma membrane signaling in HIV-1 infection.
  JOURNAL   Biochim Biophys Acta 1838:1132-42 (2014)
            DOI:10.1016/j.bbamem.2013.06.020
REFERENCE   PMID:20041213
  AUTHORS   Wu Y, Yoder A
  TITLE     Chemokine coreceptor signaling in HIV-1 infection and pathogenesis.
  JOURNAL   PLoS Pathog 5:e1000520 (2009)
            DOI:10.1371/journal.ppat.1000520
REFERENCE   PMID:22085380
  AUTHORS   Choi WT, Duggineni S, Xu Y, Huang Z, An J
  TITLE     Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).
  JOURNAL   J Med Chem 55:977-94 (2012)
            DOI:10.1021/jm200568c
REFERENCE   PMID:21321123
  AUTHORS   Vorster PJ, Guo J, Yoder A, Wang W, Zheng Y, Xu X, Yu D, Spear M, Wu Y
  TITLE     LIM kinase 1 modulates cortical actin and CXCR4 cycling and is activated by HIV-1 to initiate viral infection.
  JOURNAL   J Biol Chem 286:12554-64 (2011)
            DOI:10.1074/jbc.M110.182238
REFERENCE   PMID:15817946
  AUTHORS   Das SR, Jameel S
  TITLE     Biology of the HIV Nef protein.
  JOURNAL   Indian J Med Res 121:315-32 (2005)
REFERENCE   PMID:24822052
  AUTHORS   Roy N, Pacini G, Berlioz-Torrent C, Janvier K
  TITLE     Mechanisms underlying HIV-1 Vpu-mediated viral egress.
  JOURNAL   Front Microbiol 5:177 (2014)
            DOI:10.3389/fmicb.2014.00177
REFERENCE   PMID:22090097
  AUTHORS   Magadan JG, Bonifacino JS
  TITLE     Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu.
  JOURNAL   J Virol 86:757-72 (2012)
            DOI:10.1128/JVI.05933-11
REFERENCE   PMID:26056579
  AUTHORS   Kumar A, Herbein G
  TITLE     The macrophage: a therapeutic target in HIV-1 infection.
  JOURNAL   Mol Cell Ther 2:10 (2014)
            DOI:10.1186/2052-8426-2-10
REFERENCE   PMID:20672047
  AUTHORS   Yokota S, Okabayashi T, Fujii N
  TITLE     The battle between virus and host: modulation of Toll-like receptor signaling pathways by virus infection.
  JOURNAL   Mediators Inflamm 2010:184328 (2010)
            DOI:10.1155/2010/184328
REFERENCE   PMID:26628325
  AUTHORS   Sauter D, Kirchhoff F
  TITLE     HIV replication: a game of hide and sense.
  JOURNAL   Curr Opin HIV AIDS 11:173-81 (2016)
            DOI:10.1097/COH.0000000000000233
REFERENCE   PMID:25988887
  AUTHORS   Altfeld M, Gale M Jr
  TITLE     Innate immunity against HIV-1 infection.
  JOURNAL   Nat Immunol 16:554-62 (2015)
            DOI:10.1038/ni.3157
REFERENCE   PMID:28358311
  AUTHORS   Pasquereau S, Kumar A, Herbein G
  TITLE     Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs.
  JOURNAL   Viruses 9:E64 (2017)
            DOI:10.3390/v9040064
REFERENCE   PMID:18178131
  AUTHORS   Herbein G, Khan KA
  TITLE     Is HIV infection a TNF receptor signalling-driven disease?
  JOURNAL   Trends Immunol 29:61-7 (2008)
            DOI:10.1016/j.it.2007.10.008
REFERENCE   PMID:24453421
  AUTHORS   Kumar A, Abbas W, Herbein G
  TITLE     TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?
  JOURNAL   Mediators Inflamm 2013:484378 (2013)
            DOI:10.1155/2013/484378
REFERENCE   PMID:23986795
  AUTHORS   Abbas W, Herbein G
  TITLE     T-Cell Signaling in HIV-1 Infection.
  JOURNAL   Open Virol J 7:57-71 (2013)
            DOI:10.2174/1874357920130621001
REFERENCE   PMID:21368875
  AUTHORS   Cummins NW, Badley AD
  TITLE     Mechanisms of HIV-associated lymphocyte apoptosis: 2010.
  JOURNAL   Cell Death Dis 1:e99 (2010)
            DOI:10.1038/cddis.2010.77
REFERENCE   PMID:12766761
  AUTHORS   Gougeon ML
  TITLE     Apoptosis as an HIV strategy to escape immune attack.
  JOURNAL   Nat Rev Immunol 3:392-404 (2003)
            DOI:10.1038/nri1087
REFERENCE   PMID:21994747
  AUTHORS   Fevrier M, Dorgham K, Rebollo A
  TITLE     CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis.
  JOURNAL   Viruses 3:586-612 (2011)
            DOI:10.3390/v3050586
REFERENCE   PMID:11237054
  AUTHORS   Ross TM
  TITLE     Using death to one's advantage: HIV modulation of apoptosis.
  JOURNAL   Leukemia 15:332-41 (2001)
            DOI:10.1038/sj.leu.2402028
REFERENCE   PMID:22767237
  AUTHORS   Hurley JH, Bonifacino JS
  TITLE     Nef-arious goings-on at the Golgi.
  JOURNAL   Nat Struct Mol Biol 19:661-2 (2012)
            DOI:10.1038/nsmb.2304
REFERENCE   PMID:21762823
  AUTHORS   Wonderlich ER, Leonard JA, Collins KL
  TITLE     HIV immune evasion disruption of antigen presentation by the HIV Nef protein.
  JOURNAL   Adv Virus Res 80:103-27 (2011)
            DOI:10.1016/B978-0-12-385987-7.00005-1
REFERENCE   PMID:20594957
  AUTHORS   Laguette N, Bregnard C, Benichou S, Basmaciogullari S
  TITLE     Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins.
  JOURNAL   Mol Aspects Med 31:418-33 (2010)
            DOI:10.1016/j.mam.2010.05.003
REFERENCE   PMID:27161574
  AUTHORS   Pereira EA, daSilva LL
  TITLE     HIV-1 Nef: Taking Control of Protein Trafficking.
  JOURNAL   Traffic 17:976-96 (2016)
            DOI:10.1111/tra.12412
REFERENCE   PMID:26950141
  AUTHORS   Sugden SM, Bego MG, Pham TN, Cohen EA
  TITLE     Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence.
  JOURNAL   Viruses 8:67 (2016)
            DOI:10.3390/v8030067
REFERENCE   PMID:24906315
  AUTHORS   Bagga S, Bouchard MJ
  TITLE     Cell cycle regulation during viral infection.
  JOURNAL   Methods Mol Biol 1170:165-227 (2014)
            DOI:10.1007/978-1-4939-0888-2_10
REFERENCE   PMID:15638722
  AUTHORS   Andersen JL, Planelles V
  TITLE     The role of Vpr in HIV-1 pathogenesis.
  JOURNAL   Curr HIV Res 3:43-51 (2005)
            DOI:10.2174/1570162052772988
REFERENCE   PMID:17140287
  AUTHORS   Andersen JL, DeHart JL, Zimmerman ES, Ardon O, Kim B, Jacquot G, Benichou S, Planelles V
  TITLE     HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.
  JOURNAL   PLoS Pathog 2:e127 (2006)
            DOI:10.1371/journal.ppat.0020127
REFERENCE   PMID:23430691
  AUTHORS   Takaori-Kondo A, Shindo K
  TITLE     HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors.
  JOURNAL   Front Microbiol 4:34 (2013)
            DOI:10.3389/fmicb.2013.00034
REFERENCE   PMID:19038776
  AUTHORS   Malim MH
  TITLE     APOBEC proteins and intrinsic resistance to HIV-1 infection.
  JOURNAL   Philos Trans R Soc Lond B Biol Sci 364:675-87 (2009)
            DOI:10.1098/rstb.2008.0185
REFERENCE   PMID:21835787
  AUTHORS   Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, Harris RS
  TITLE     Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.
  JOURNAL   J Virol 85:11220-34 (2011)
            DOI:10.1128/JVI.05238-11
REL_PATHWAY hsa03050  Proteasome
            hsa04010  MAPK signaling pathway
            hsa04020  Calcium signaling pathway
            hsa04064  NF-kappa B signaling pathway
            hsa04110  Cell cycle
            hsa04141  Protein processing in endoplasmic reticulum
            hsa04142  Lysosome
            hsa04150  mTOR signaling pathway
            hsa04151  PI3K-Akt signaling pathway
            hsa04210  Apoptosis
            hsa04612  Antigen processing and presentation
            hsa04620  Toll-like receptor signaling pathway
            hsa04623  Cytosolic DNA-sensing pathway
            hsa04668  TNF signaling pathway
            hsa04810  Regulation of actin cytoskeleton
KO_PATHWAY  ko05170
///
